Type IV secretion (T4S) systems are involved in several secretion processes, including secretion of virulence factors, such as toxins or transforming molecules, or bacterial conjugation whereby two mating bacteria exchange genetic material. T4S systems are generally composed of 12 protein components, three of which, termed VirB4, VirB11, and VirD4, are ATPases. VirB4 is the largest protein of the T4S system, is known to play a central role, and interacts with many other T4S system proteins. In this study, we have biochemically characterized the protein TraB, a VirB4 homologue from the pKM101 conjugation T4S system. We demonstrated that TraB is a modular protein, composed of two domains, both able to bind DNA in a non-sequencespecific manner. Surprisingly, both TraB N-and C-terminal domains can bind ATP, revealing a new degenerated nucleotide-binding site in the TraB N-terminal domain. TraB purified from the membrane forms stable dimers and is unable to hydrolyze ATP while, when purified from the soluble fraction, TraB can form hexamers capable of hydrolyzing ATP. Remarkably, both the N-and C-terminal domains display ATP-hydrolyzing activity. These properties define a new class of VirB4 proteins.
The type IV secretion (T4S) systems are widely distributed among the Gram-negative and -positive bacteria. T4S systems export proteins and DNA-protein complexes across the bacterial cell envelope to other bacteria or eukaryotic cells, generally through a process requiring direct cell-to-cell contact (10, 11, 16) . T4S systems have been grouped according to sequence relatedness of machine components, with systems homologous to the archetypal VirB/VirD4 T4S system of Agrobacterium tumefaciens being classified as type IVA and those related to the Dot/Icm T4S system of Legionella pneumophila being classified as type IVB (12) . T4S systems fulfill a wide variety of functions, such as mediating the conjugative transfer of plasmids and other mobile DNA elements to bacterial recipient cells or delivering protein or DNA substrates to eukaryotic cells. Another kind of T4S system-related process is DNA release or uptake, whereby DNA substrates are exchanged with the extracellular milieu (8, 16) .
T4S-related machineries are used by several plant and human pathogens for the purpose of delivering virulence effectors to eukaryotic cell targets. Such pathogens include extracellular organisms such as A. tumefaciens, which is the causative agent of crown gall disease in plants, Bordetella pertussis, which is the agent responsible for whooping cough in children, and Helicobacter pylori, which is responsible for gastric ulcers and stomach cancer (3, 6, 13, 34) . In addition, there are intracellular bacterial pathogens using T4S systems for their virulence, such as Brucella suis, the causative agent of brucellosis, and L. pneumoniae, the causative agent of Legionnaires' disease (5, 30) .
T4S systems are generally composed of 12 protein components forming a macromolecular assembly inserted into the bacterial cell envelope. These proteins are named VirB1 to VirB11 and VirD4, based on the widely used nomenclature of the model system, the A. tumefaciens VirB/D4 T4S system (16) . Three putative ATPases are key components of the T4S system: VirD4, VirB11, and VirB4. VirB4 proteins are the largest and most evolutionarily conserved proteins in T4S systems (15) . VirB4 proteins are suggested to be located in the inner membrane, either directly and/or indirectly through their interactions with other components of the T4S system (14, 18, 31) . An important feature of VirB4 proteins is the presence of Walker A and Walker B motifs characteristic of ATPases (29) . But until very recently no nucleoside triphosphatase (NTPase) activity had been demonstrated for any VirB4 homologue. However, the VirB4 homologue of plasmid R388, the protein TrwK, has now been shown to possess an ATPase activity (2) . Very little structural information is available for the VirB4 subunit family. Recently, a bioinformatics model based on the structural similarities between the Agrobacterium VirB4 C terminus and TrwB (VirD4 homolog) proposed that the VirB4 C terminus forms a discrete domain that assembles as a homohexameric ring (26) , much like VirB11 and VirD4 (19, 33) .
Here, we report a comprehensive biochemical study of the TraB protein, the VirB4 homologue from the pKM101 conjugation machinery. Our results suggest that TraB exists under two forms: a dimeric membrane form and a primarily hexameric soluble form. Both bind DNA nonspecifically and also ATP; however, only the hexameric form hydrolyzes ATP. TraB has a clear modular structure composed of two large contiguous domains that split the protein roughly in two. While only the C-terminal domain was known to contain a nucleotide-binding site, we establish that both domains can bind and hydrolyze ATP. Also, both cooperate to bind DNA. Our study also reveals a complex interplay between the two domains. Our results provide crucial but singular insights that suggest previously unsuspected properties of a family of proteins that play critical functions in T4S systems.
(20 mM Tris-HCl [pH 7.5], 300 mM NaCl, 1 mM ␤ME; sol indicates buffer used to purify the soluble forms of TraB proteins) plus 4% of buffer B sol (20 mM Tris-HCl [pH 7.5], 300 mM NaCl, 1 mM ␤ME, 500 mM imidazole). The column was then washed with 100 ml of buffer A sol plus 8% buffer B sol . Finally the proteins still bound to the column were eluted in a gradient from 8% to 100% of buffer B sol in 100 ml. Eluted fractions containing the protein of interest were pooled and concentrated in less than 4 ml before being loaded onto a HiPrep 16/60 Sephacryl S-300 HR column (Amersham) equilibrated in the gel filtration (GF) buffer GF sol containing 20 mM Tris-HCl (pH 7.5), 50 mM NaCl, and 1 mM ␤ME or in a buffer with acetate, termed GF acetate-sol and containing 50 mM HEPES-NaOH (pH 7.0), 75 mM potassium acetate, 2 mM magnesium acetate, 10% (wt/vol) glycerol, and 0.1 mM EDTA (see also the Results and Discussion section for the naming of the gel filtration buffers). The protein of interest eluted as a single peak. Fractions under this peak were pooled.
TraB FL and TraB NT were also purified from the membranes. When proteins were purified from membrane extracts, the following protocol was applied. The cells were defrosted and resuspended in a buffer (3 ml per g of cell paste) containing 20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM ␤ME, and one tablet of EDTA-free protease inhibitor cocktail (Roche). After cells were broken by two passages through an EmulsiFlex-C5 homogenizer and DNA was fragmented by sonication, unbroken cells were removed by centrifugation at 14,000 rpm for 10 min in a Sorvall SS-34 rotor. Total membranes were pelleted by ultracentrifugation (45 min at 100,000 ϫ g at 4°C) and resuspended in buffer EB (20 mM Tris-HCl [pH 7.5], 50 mM NaCl, 1 mM ␤ME, 1% [vol/vol] Triton X-100) supplemented with one tablet of EDTA-free protease inhibitor cocktail (Roche). Membrane-embedded proteins were extracted during 1 h at 4°C. The membrane extract was further clarified by ultracentrifugation (30 min at 100,000 ϫ g at 4°C). Triton X-100 was used only for extraction; then it was replaced by the hydrogenated Triton X-100 [Triton X-100 (H) ; Calbiochem] that does not absorb UV light. We further used a concentration of 0.01% Triton X-100 (H) (0.16 mM) because this is below the critical micelle concentration (CMC) of the detergent (0.2 to 0.9 mM), thus avoiding the formation of detergent micelles. The cleared extract was loaded onto a HisTrap HP 5-ml column (GE Healthcare) equilibrated in buffer A mb [20 mM Tris-HCl (pH 7.5(, 300 mM NaCl, 1 mM ␤ME, 0.01% Triton X-100 (H) ; mb indicates the buffer used to purify the membrane forms of TraB proteins] plus 4% of buffer B mb [20 mM Tris-HCl (pH 7.5), 300 mM NaCl, 1 mM ␤ME, 0.01% Triton X-100 (H) , 500 mM imidazole]. The column was then washed with 100 ml of buffer A mb plus 6% buffer B mb . Finally, the proteins still bound to the column were eluted in a gradient from 6% to 100% of buffer B mb in 100 ml. Eluted fractions containing either TraB FL or TraB NT were pooled and concentrated in less than 4 ml before being loaded onto a HiPrep 16/60 Sephacryl S-300 HR column (Amersham) equilibrated in either buffer GF mb containing 20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM ␤ME, and 0.01% Triton X-100 (H) or buffer GF acetate-mb containing 50 mM HEPES-NaOH (pH 7.0), 75 mM potassium acetate, 2 mM magnesium acetate, 10% (wt/vol) glycerol, 0.1 mM EDTA, and 0.01% Triton X-100 (H) (see also the Results and Discussion section for the naming of the gel filtration buffers). The proteins TraB FL and TraB NT both eluted as a single peak. Fractions under this peak were pooled.
The apparent molecular mass of proteins eluted from the gel filtration column was deduced from a calibration carried out with low-and high-molecular-weight calibration kits (Amersham Biosciences). In addition to dynamic light scattering (DLS; described below), the molecular weights of the various multimeric forms were assessed using 3 to 12% or 4 to 16% blue native (BN)-PAGE (Invitrogen). Determination of protein concentration was carried out by using either the theoretical absorption coefficients (mg/ml ⅐ cm) at 280 nm as obtained with the program ProtParam at the EXPASY server (available on the World Wide Web at www.expasy.ch/tools) or a Bio-Rad protein assay reagent (Bio-Rad).
ATPase assays. Two sets of assays were carried out to assess the ATPase activity of all purified proteins. For the first set of assays, we used the proteins in GF sol for the soluble forms or those in GF mb for the membrane forms. The ATPase assays were carried out using an Innova Bioscience kit, which required that the assay be performed in a final buffer containing 50 mM Tris-HCl (pH 7.4), 25 mM NaCl, 2.5 mM MgCl 2 , and 0.5 mM ATP (the enzyme concentration was 70 M [in monomer equivalent]).
For the second set of ATPase assays, we used the proteins in GF acetate-sol for the soluble forms and those in GF acetate-mb for the membrane forms. ATPase activity was monitored using a coupled-enzyme assay (24) . A total of 44 l of TraB FL (3.3 M), TraB NT (7.5 M), and TraB CT (10.3 M) in GF acetate-sol (for the soluble forms of the three proteins) or in GF acetate-mb (for the membrane forms of TraB FL and TraB NT ) was incubated in 400 l of ATP assay buffer, consisting of 50 mM PIPES [piperazine-N,NЈ-bis(2-ethanesulfonic acid)]-NaOH (pH 6.45), 75 mM potassium acetate, 5% (wt/vol) glycerol, 10 mM magnesium acetate, 1 mM potassium chloride, 1 mM dithiothreitol, 0.1 mM EDTA, 0.5 mM phosphoenolpyruvate, 0.25 mM NADH, 60 g/ml pyruvate kinase, 60 g/ml lactate dehydrogenase, and 0.0625 to 10 mM ATP. The reaction mixtures were preincubated at 37°C for 2 min, after which the ATPase assay was started by the addition of various concentrations of ATP. Activity was measured by the decrease in NADH absorbance at 340 nm for 15 min at 37°C in a UV-visible spectrophotometer (CARY 3; Varian) and the slopes (absorbance/min) were calculated by the program Kinetics-CARY. All the data sets were fitted to a Michaelis-Menten equation: 
Note that adding 0.01% Triton to the soluble form of TraB FL did not affect its ATPase activity; thus, 0.01% Triton does not affect ATPase activity of TraB proteins. DLS. Dynamic light-scattering experiments were performed with a DynaPro-801 (Protein Solutions) at room temperature. All samples were filtered prior to the measurements (Millex syringe filters; 0.22-m pore size; Millipore Corp.). The hydrodynamic radius was deduced from translational diffusion coefficients using the Stokes-Einstein equation. Diffusion coefficients were inferred from the analysis of the decay of the scattered intensity autocorrelation function. All calculations were performed using the software provided by the manufacturer (Dynamics, version 5.25.44).
DNA mobility assay. Proteins (in GF sol or GF mb ) at various concentrations and DNA (pKM101 plasmid or PCR product) were mixed and incubated for 10 min at room temperature. A small volume of loading buffer (0.005% bromophenol blue-20% [wt/vol] sucrose) was added to the sample before it was loaded on a native agarose gel prepared using 0.3% or 0.4% agarose dissolved in SYBR Safe DNA gel stain (Invitrogen) in 0.5ϫ TBE (Tris-Borate-EDTA) buffer to visualize the free DNA and the protein-DNA complex bands. Gels were electrophoresed at 100 V for 90 min to 2 h at room temperature in 0.5ϫ TBE buffer. Free DNA and DNA-protein complex bands were visualized under a UV lamp.
Limited trypsin proteolysis. Protein and DNA (pKM101 plasmid) were preincubated for 10 min on ice in buffer GF mb or GF sol prior to the addition of trypsin (0.3 g/ml). The reactions were allowed to proceed on ice for 60 min. At various time points (0, 15, 30, 45, and 60 min), an aliquot was removed from the reaction mixture, and NuPAGE lithium dodecyl sulfate (LDS; 4ϫ) sample buffer (Invitrogen) was added. Samples were boiled for 10 min and then loaded on a Nu-PAGE (4 to 12%) gel (Invitrogen) and electrophoresed for 35 min at 200 V in NuPAGE morpholinepropanesulfonic acid (MOPS)-SDS running buffer (Invitrogen). After electrophoresis the gel was stained with SimplyBlue SafeStain (Invitrogen).
Fluorescence measurements. The fluorescent ATP nucleotide analogue 3Ј(2Ј)-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP) was purchased from Molecular
Probes. Fluorescence measurements were performed on a Hitachi F2500 Fluorescence Spectrophotometer, and all the data were processed using the software FL Solutions F-2500. The excitation wavelength was set at 410 nm, and the emission wavelength was scanned in the 470-and 650-nm range. TNP-ATP binding was calculated from the fluorescence maxima determined graphically. The temperature of the sample was maintained at 20°C by circulating thermostatically controlled water through the cuvette holder. 
where ⌬F represents the relative fluorescence intensity, ⌬F min is the relative fluorescence intensity at the start of the titration, ⌬F max is the relative fluorescence intensity at a saturating concentration of TNP-ATP (L), E t is the total concentration of protein (monomer equivalent), and K d TNP-ATP is the apparent dissociation constant of the protein-TNP-ATP complex.
In the case of displacement of bound TNP-ATP by ATP, the following quadratic equation was used (21) :
where ⌬F max is the relative fluorescence intensity at the start of the titration, and ⌬F min is the relative fluorescence intensity at saturating concentration of MgATP, K 0.5 represents here the amount of MgATP necessary to displace half the amount of bound TNP-ATP, and L represents the MgATP concentration. We then used the K 0.5 value obtained from the displacement experiments and the following equation to calculate the apparent dissociation constant of the proteinMgATP complex (K d ATP ):
where L represents the TNP-ATP concentration at the start of the titration.
RESULTS AND DISCUSSION
Identification and production of TraB domains. TraB, like other VirB4 proteins, contains a nucleoside triphosphate (NTP)-binding site encompassing the Walker A and Walker B motifs located in the second half of the protein sequence (Fig. 1A,  NBD ). This C-terminal region (residues 448 to 848) is also the most conserved among VirB4 proteins and, as already suggested by Middleton et al. (26) might be similar in structure to the soluble domain of TrwB, a VirD4 homolog (19; see also Fig. S1 in the supplemental material). Therefore, we decided to clone and express individually the N-and C-terminal domains of TraB, together with the full-length protein ( Fig. 1 and Materials and Methods). The three proteins were expressed in E. coli as N-terminally His 6 -tagged recombinant proteins. The C-terminal domain of TraB (TraB CT ) was purified from the soluble fraction (see Materials and Methods). However, because a distinct single transmembrane domain (TM) in the N-terminal region of TraB is predicted (http://www.sbc.su .se/ϳmiklos/DAS/), the full-length TraB (TraB FL ) and the Nterminal domain of TraB (TraB NT ) were initially purified from the membrane fraction. However, we noticed that both TraB FL and TraB NT (Fig. 1B) . However, gel filtration analysis indicated that the proteins are oligomeric. Oligomerization was tested under two buffer conditions established at the final gel filtration stage of the purification. These conditions together with the cell compartment from which the proteins originate (cytosol or membrane) are referred to in Materials and Methods and thereafter as GF sol , GF acetate-sol , GF mb , and GF acetate-mb , where sol and mb refer to the soluble cytosolic and membrane forms of the proteins, respectively, and acetate indicates that the buffer contains acetate. The membrane form of TraB FL in GF mb is primarily dimeric, as assessed by BN-PAGE and gel filtration (see Fig. S2A in the supplemental material) although higher-order oligomers (tetramers and hexamers) are also observed using BN-PAGE. The fractions containing the dimers of membrane-extracted TraB FL were selected. These dimers are stable over time and were used for subsequent studies of the membrane form of TraB FL . TraB NT purified from the membrane fraction is overwhelmingly dimeric, in GF mb , although large aggregates eluting in the void volume are observed, indicating a tendency of the protein to aggregate (see Fig. S2B Fig. S2C in the supplemental material). All three were, however, hexameric in GF acetate-sol , as assessed using gel filtration (data not shown) and DLS (Table 1) . Thus, we conclude that the soluble forms of TraB CT , TraB FL , and TraB NT transition between at least two forms, dimeric and hexameric, which are in a dynamic equilibrium where one form is favored over the other depending on solution conditions, notably the presence or absence of acetate ions. Whether the membrane forms of TraB FL and TraB NT also transition between two oligomeric states remains to be investigated. It is, however, interesting that these proteins do not display ATPase activities even in the presence of acetate ions (see "ATP hydrolysis of TraB proteins" below), suggesting that dimeric TraB FL and TraB NT might not be able to transition to higher oligomeric forms. This could be caused by the presence of detergent in the GF acetate-mb buffer, but it was shown that detergent does not disrupt ATPase activities of the soluble TraB protein forms (see "ATP hydrolysis of TraB proteins" below).
These results contrast with those obtained on the full-length TrwK protein, the VirB4 homologue in the R388 plasmid system, for which no membrane form has been identified. TrwK was found to be soluble and primarily monomeric although a minor hexameric form accounting for 5% of the total species was ascribed as the ATP-hydrolyzing form (2) . Also, no TrwK fragment has been studied.
Because TrwK has already been the subject of extensive studies, we decided to focus subsequent work on TraB and TraB fragments primarily (but not exclusively; see ATPase assay results below), specifically, on the dimeric, membrane forms of TraB FL and TraB NT (purified in GF mb ) and on the dimeric soluble form of TraB CT (purified in GF sol ). Interaction of TraB-derived constructs with DNA. Because TraB is a component of a T4S system transporting DNA, we investigated whether TraB could bind DNA. First, we showed that TraB FL (membrane form in GF mb ) is protected from proteolysis degradation after being incubated in the presence of the pKM101 DNA ( Fig. 2A) . This result suggested that TraB was able to interact with the pKM101 DNA. In a second approach, we demonstrated that TraB FL could shift the migration of the pKM101 DNA on a native agarose gel in a concentration-dependent manner (results not shown). However, this interaction is not DNA sequence specific since TraB FL could also shift the migration of a random PCR product (Fig. 2B) . We conclude that TraB FL can bind DNA nonspecifically. Then, we asked which of the two TraB domains is responsible for DNA binding. Interestingly, both the N-terminal (TraB NT ; membrane form in GF mb ) and C-terminal (TraB CT ; dimeric soluble form in GF sol ) domains of TraB were able to bind either the pKM101 DNA (results not shown) or a random PCR product (Fig. 2B) . In this assay, an unrelated protein (bovine serum albumin [BSA]) was unable to bind the PCR product (Fig. 2B) . In conclusion, we demonstrated that TraB can bind DNA in a non-sequence-specific manner and that both the N-terminal and C-terminal domains are involved in binding. Interestingly, although the end shift positions are similar for all three proteins, saturation occurs more rapidly for TraB CT than for either TraB FL or TraB NT . This indicates an influence of TraB NT on DNA binding of TraB CT .
TraB-derived proteins can bind ATP. Until now, only one conserved nucleotide-binding site has been identified in TraB, and the site is located in its C-terminal domain (Fig. 1) . This prompted us to investigate whether TraB CT could bind ATP. We used fluorescence spectroscopy to monitor the interaction of the fluorescent ATP analogue TNP-ATP with the protein. Upon protein binding, the fluorescence emission intensity of TNP-ATP increases considerably, with the absolute magnitude dependent on the specific protein environment; thus, it has been widely used to characterize ATP binding by a number of proteins (9, 25) . As expected, we showed that TraB CT (soluble dimeric form in GF sol ) was able to bind TNP-ATP, as demon- strated by the remarkable enhancement of the emission intensity of TNP-ATP in the presence of TraB CT (Fig. 3A) together with a blue shift (from 552 to 546 nm) of the wavelength of maximal emission. Moreover, bound TNP-ATP could be dislodged from its binding site, at least partially, by excess ATP (Fig. 3B) , indicating that the reported TNP-ATP-enhanced emission intensity is caused by binding to a bona fide ATPbinding site (21, 32) . TraB CT represents just one half of the full-length TraB (TraB FL ). So, we wanted to check if the rest of the protein could influence the ATP-binding property of the C-terminal domain of TraB. We used fluorescence spectroscopy to monitor the interaction of TNP-ATP with TraB FL and TraB NT , both purified from the membrane fraction (i.e., in GF mb ). Similarly to TraB CT , TraB FL was able to bind TNP-ATP (Fig. 3A) , albeit with a slightly different absolute magnitude that could indicate a different protein environment around the bound TNP-ATP. Furthermore, TNP-ATP binding was efficiently competed by adding an excess of ATP (Fig. 3A) . Surprisingly, TraB NT also binds TNP-ATP, a binding reaction that was also competed by an excess of ATP (Fig. 3A) . The latter result was unexpected, given that the only reported nucleotide-binding site in VirB4 proteins is located in the C-terminal half (Fig. 1) .
The three TraB proteins (the soluble dimeric TraB CT in GF sol and the membrane TraB FL and TraB NT in GF mb ) were next titrated with increasing amounts of TNP-ATP, and the results were fitted to equation 3 of Materials and Methods (Fig. 3B) (28) , but both of them are highly conserved. Conversely, the translocon protein SecA has two nucleotide-binding sites (see Fig. S3A in the supplemental material), a high-affinity site in the N-terminal domain (NBD1) and a low-affinity site in the C-terminal domain (NBD2) (27) ; the low-affinity site is far less conserved in its amino acids sequence than the high-affinity site. We thus performed a sequence alignment between the N-terminal domain of TraB and the C-terminal domain of SecA (see Fig.  S3B) . Surprisingly, the two domains exhibit a high degree of sequence identity (28%) (see Fig. S3B ). Moreover, two regions in the TraB N-terminal domain align with the sequences known to form the Walker A and B motifs in the C-terminal domain of SecA (see Fig. S3B ). Notably, key residues (GRX TXD) in the Walker A motif of SecA are conserved in TraB NT (20) . We concluded that, like the SecA C-terminal domain, the N-terminal domain of TraB also contains a poorly conserved nucleotide-binding site. We then asked if this new feature in the N-terminal domain of TraB was conserved among the VirB4 protein family. As shown in Fig. 4 , the nucleotide-binding site in the N-terminal domain of TraB seems to be poorly conserved among VirB4 proteins. Indeed, just 3 out of the 38 VirB4 homologues aligned, including TraB, present a motif similar to the SecA low-affinity NTP-binding site. Thus, we have identified a new ATP-binding site in the N-terminal domain of TraB that defines a new class of VirB4 proteins ( Fig.  4 ; see also and Fig. S3C and S4 in the supplemental material) .
ATP hydrolysis of TraB proteins. Recently, the first demonstration of an ATPase activity for a VirB4 homolog was described for the protein TrwK from the plasmid R388 T4S system conjugation system (2) . ATPase assays of TraB and TraB fragments were carried out under two sets of conditions (see Materials and Methods), i.e., in a buffer similar to GF sol / GF mb and in a buffer similar to GF acetate-sol /GF acetate-mb . In GF acetate-sol , TraB CT was found to hydrolyze ATP. Under such conditions, it is also hexameric (see above). TraB CT kinetic parameters for ATP hydrolysis were determined by analyzing the effect of ATP concentration on ATPase activity rates (Fig. 5) . The data were fitted to the Michaelis-Menten equation 1, from which we calculated the kinetic parameters. Table  2 ) (note that in all calculations, the monomer-equivalent concentration was used). Subsequently, in order to assess the relevance of this ATPase activity, we constructed a Walker A derivative of TraB CT carrying a point mutation K503A (see Material and Methods), that has been shown to be of crucial importance for ATPase activity in many proteins (22, 23 (Table 2) . Surprisingly, soluble hexameric TraB NT in GF acetate-sol was also able to hydrolyze ATP (Fig. 5) . TraB NT shows a V max of 6.80 Ϯ 0.24 mol of ATP hydrolyzed per min per mol of enzyme, which is higher than that of TraB CT but lower than that of TraB FL , and a similar K m of 0.48 Ϯ 0.07 mM compared to the other two proteins ( Table 2) . As mentioned previously, we identified a poorly conserved ATP-binding site in the N-terminal domain of TraB (NBD1). In order to check the specific involvement of this NBD1, we designed a point mutation replacing Arg53 by Ala (R53A) in TraB FL and in TraB NT (see Materials and Methods). The wild-type protein with the R53A mutation, TraB FL RAWT , shows a marked decrease in its ATPase activity (3.10 Ϯ 0.24 mol of ATP hydrolyzed per min per mol of enzyme) compared to TraB FL (Table 2) NT is not caused by detergent but, instead, may reflect the fact that these proteins remain dimeric even in the presence of acetate ions. This would suggest that TraB in the membrane might be constitutively dimeric.
The effect of DNA binding on ATPase activity of TraB proteins was tested, and no difference in ATPase kinetic parameters was observed. Thus, DNA binding does not affect ATPase activity.
Conclusions. In the study presented here, we have unraveled a number of features of VirB4 proteins that were not apparent in TrwK, the other VirB4 protein for which extensive biochemical characterization has been carried out (2) . TraB partitions between the membrane and the cytoplasm, apparently adopting two distinct oligomeric states, each of which is characterized by a different ATP-hydrolyzing property. The form extracted from the membrane is dimeric and unable to hydrolyze ATP although it is able to bind DNA and nucleotide. Interestingly, in a buffer with NaCl and no acetate ions, the soluble form of TraB is also dimeric and also unable to hydrolyze ATP while in the absence of NaCl but in acetate, it is hexameric and able to hydrolyze ATP. Thus, we conclude that TraB can hydrolyze ATP only when in a hexameric state. TrwK differs from TraB in being exclusively cytoplasmic and primarily monomeric in low-salt buffer conditions. Higher oligomeric forms of TrwK were observed in acetate buffer, but only up to 5% of protein was assessed to be hexameric, a form that was hypothesized to be the ATP-hydrolyzing form. The results with TraB are therefore less ambiguous in ascribing the ATP-hydrolyzing form of the protein to the hexameric form. Interestingly, TraB is able to transition from the soluble dimeric inactive form to a soluble active hexameric form, demonstrating that the protein is highly dynamic.
VirB4 proteins are likely to be located at the base of the core machinery, embedded or associated with the inner membrane (16, 17) . It is intriguing that TraB purifies as an inactive dimer when extracted from the membrane. It could be that in the physiological conditions of the cell at the cytoplasmic face of the inner membrane (characterized by a low NaCl concentration), the protein transitions to a hexamer even in the context of the membrane. However, two other mechanisms could lead to an active TraB in the membrane: (i) a change in oligomerization from dimer to hexamer caused by the association with other T4S system components; (ii) the binding of an ATPaseactivating protein, leaving TraB dimeric but inserting in trans activating residues missing at the ATP-binding interface in the dimer. Regarding the former, it is possible that the association of VirB4 with the core complex might lead to a change in the oligomerization state. Possibly a VirB4-VirB11 interaction also could affect the oligomerization state of VirB4 as VirB11 is constitutively hexameric. Regarding the latter, there are examples of proteins that contain motifs known to be able to complete in trans ATPase active sites; one such motif is the wellcharacterized "Arg finger" of GAP proteins (1). VirB3 is known to associate with VirB4 as both are sometimes found in tandem in the same protein (4, 10) . VirB3 has been proposed to locate VirB4 to the membrane for the VirB4 variants that are not endowed with transmembrane segments. However, VirB3 could also influence VirB4 oligomerization and activity in such a way that, when embedded in the entire machinery, a dimeric VirB4 could be rendered active.
Fragments of TraB recapitulate the behavior of the fulllength protein in terms of oligomerization and ATP-hydrolyzing activity. Indeed, the soluble form of the C-terminal domain and both the soluble and membrane-bound forms of the Nterminal domain of TraB are dimeric and unable to hydrolyze ATP under NaCl-containing (GF sol or GF mb ) buffer condi- on July 6, 2017 by guest http://jb.asm.org/ tions. Moreover, the soluble forms of these domains are able to transition from dimer to hexamer depending on the salt versus acetate conditions. However, remarkably-and demonstrating a property unique to TraB among VirB4 proteins-both domains are able to bind and hydrolyze ATP. This led us to identify a novel cryptic but functional ATP-binding site in the N-terminal domain of the protein.
Another intriguing result is the ability of TraB and both of its domains to bind DNA. A previous study of DNA-binding by VirB4-like proteins reported that these proteins were unable to bind DNA (29) . Until now, only the coupling protein VirD4 has been shown to bind DNA (32) . The functional significance of DNA binding by TraB is difficult to square with the reported result that VirB4 does not contact DNA directly during substrate transfer by the A. tumefaciens VirB/D4 T4S system (7). This could indicate that there are some differences between T4S systems and that, in the case of conjugation by the pKM101-encoded T4S system, DNA makes contact with TraB, perhaps relaying substrate transfer from the VirD4-homolog in this system. However, in the absence of a mutation in TraB that abrogates DNA binding, it would be difficult to speculate further as to whether DNA binding by this protein plays a fundamental role in conjugation.
